Navigation Links
Registration Now Open for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego

SAN DIEGO, March 5, 2013 /PRNewswire/ -- The Association of Bioscience Financial Officers (ABFO) today announced the opening of registration for the 2013 National Conference, which will be held May 28-31 at the Hilton San Diego Bayfront.

Approximately 200 financial executives from life sciences companies are expected to attend the conference to network and discuss how they can create and capture value for their respective organizations. The conference includes keynote speakers and breakout panels all with a focus on value beyond just the areas of finance and accounting, encompassing operational excellence, business development, regulatory expertise and team building.  

"Financial executives play a critical role in the operations of their organizations," said Brandi Roberts , Chief Financial Officer of ADVENTRX Pharmaceuticals, Inc. and the 2013 National Conference Chair. "At this year's national conference, we want to take a closer look at how we can add value to our organizations. We have a stellar lineup of thought leaders from the bioscience industry to prepare us for new challenges and opportunities ahead."

ABFO will welcome numerous keynote speakers, including:

  • Michael Abrashoff, former Navy Commander and author, who will talk about his leadership strategies as documented in his book "It's Your Ship"
  • Dan Bradbury , former President and CEO, and Mark Foletta , former CFO, of Amylin Pharmaceuticals who will discuss exit strategies by giving a first-hand account of "The Amylin Story"
  • Joe Quinlan , Managing Director and Chief Market Strategist of U.S. Trust – Bank of America who is a repeat presenter at the ABFO national conference and will present a lively overview on the state of the US economy
  • Karin Eastham , director for 4 public biotechnology companies, will discuss what directors expect from CFOs today – and it's not just about the numbers!

In addition to the keynote presentations, attendees of the conference will also be able to participate in break-out sessions led by industry executives with first-hand expertise in each area, including:

  • Effective Management of Clinical Trials and CROs
  • Current D&O Landscape and Say on Pay
  • Update on IPOs
  • Lean in Biosciences
  • M&A Considerations
  • Treasury-Navigating Change
  • Role of Orphan Drugs in Biotech/Pharma
  • Accounting and SEC Update

Registration can be completed online at through May 15, 2013.  The cost to attend the conference is only $1,200 and 15 hours of continuing education credits are available.  For more information about the conference, contact Brandi Roberts at

Sponsors of the event include AON, Bank of America Merrill Lynch, Brinson Patrick , Ernst & Young, Oxford Finance and Cooley LLP.  The conference is also supported by Russo Partners, PR Newswire and BioCentury.

About the Association of Bioscience Financial Officers

Formed in 1989, the Association of Bioscience Financial Officers has eleven chapters that serve as forums for the exchange of information about the industry and networking. Regional chapters are based in top bioscience concentrations to allow for face-to-face meetings and discussion of hot topics of interest to bioscience financial officers. The regional chapters meet annually for the ABFO National Conference for extended networking. For more information, visit

SOURCE Association of Bioscience Financial Officers (ABFO)
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology
2. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
3. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
4. Regulus Files Registration Statement for Proposed Initial Public Offering
5. Bayer CropScience Announces Registration for use of Alion on Grapes in California
6. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
7. Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
8. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
9. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
10. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
11. Inovios Scientific Advisory Board Chairman Elected as a Fellow by the American Association for the Advancement of Science
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... 24, 2015  Clintrax Global, Inc., a worldwide provider of clinical ... today announced that the company has set a new quarterly earnings ... on quarter growth posted for Q3 of 2014 to Q3 of ... Mexico , with the establishment of an ... --> United Kingdom and Mexico ...
(Date:11/24/2015)... , November 24, 2015 ... recent market research report released by Transparency Market Research, ... expand at a CAGR of 17.5% during the period ... Testing Market - Global Industry Analysis, Size, Volume, Share, ... global non-invasive prenatal testing market to reach a valuation ...
(Date:11/24/2015)... ... 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions for production, ... to serve as Chief Operating Officer. , Having joined InSphero in November ... and was promoted to Head of InSphero Diagnostics in 2014. There she has ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
Breaking Biology News(10 mins):